|
|
(Transportation-News.com, August 27, 2018 ) Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents are bacteria, viruses, fungi, or toxins, and may be in a naturally occurring or a human-modified form, in much the same way in biological warfare.
Bioterrorism refers to form of terrorism that involves intentional dissemination or release of biological agents. The agents can be viruses, bacteria or toxins and can also be referred to as germ warfare. Biological agents are mainly found in nature but sometimes they can be modified by the terrorist as to make agents more toxic. Biological agents are used by the terrorists to attain their social or political goals and are used for killing or injuring people, plants and animals. Biological weapons are dangerous as some of these agents are transmitted from one person to another and infection might take hours or days to become noticeable.
Bioterrorism is an invaluable tool as biological agents are relatively inexpensive and can cause widespread fear beyond the actual damage they can cause. They are mainly used by the terrorists to create mass panic and disruption of state or economy. The global market for bioterrorism is segmented on the type of different biological agents currently being used and their mode of delivery. Agents such as anthrax, tularemia, small pox, bubonic plague, botulinum toxin and viral hemorrhagic fevers pose a high threat to national security.
The "Global Bioterrorism Market Analysis to 2025" is a specialized and in-depth study of the Bioterrorism industry with a focus on the global market trend. The report aims to provide an overview of global Bioterrorism market with detailed market segmentation by product, technology, application, end user and geography.
Get PDF Sample Brochure | http://www.reportsweb.com/inquiry&RW00012207697/sample
The global Bioterrorism market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
This report studies the global market size of Bioterrorism in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bioterrorism in these regions.
The key manufacturers in the Bioterrorism include
Altimmune
Bavarian Nordic
DynPort Vaccine Company (DVC)
Emergent BioSolutions
Acambis
Achaogen
Cleveland BioLabs
Elusys Therapeutics
Market segment by Type, the product can be split into
Anthrax
Smallpox
Botulism
Radiation/Nuclear defense
Others
Market segment by Application, split into
Military
Government
Inquire before Purchase “Global Bioterrorism Market Analysis to 2025” | http://www.reportsweb.com/inquiry&RW00012207697/buying
(Note: If you have any special requirements, please let us know and we will offer you the report as you want.)
The study objectives are:
To analyze and research the global Bioterrorism status and future forecast, involving, production, revenue, consumption, historical and forecast.
To present the key Bioterrorism manufacturers, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Bioterrorism Market Manufacturers Profiles
12.1 Altimmune
12.1.1 Altimmune Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bioterrorism Introduction
12.1.4 Altimmune Revenue in Bioterrorism Business (2013-2018)
12.1.5 Altimmune Recent Development
12.2 Bavarian Nordic
12.2.1 Bavarian Nordic Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bioterrorism Introduction
12.2.4 Bavarian Nordic Revenue in Bioterrorism Business (2013-2018)
12.2.5 Bavarian Nordic Recent Development
12.3 DynPort Vaccine Company (DVC)
12.3.1 DynPort Vaccine Company (DVC) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bioterrorism Introduction
12.3.4 DynPort Vaccine Company (DVC) Revenue in Bioterrorism Business (2013-2018)
12.3.5 DynPort Vaccine Company (DVC) Recent Development
12.4 Emergent BioSolutions
12.4.1 Emergent BioSolutions Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bioterrorism Introduction
12.4.4 Emergent BioSolutions Revenue in Bioterrorism Business (2013-2018)
12.4.5 Emergent BioSolutions Recent Development
12.5 Acambis
12.5.1 Acambis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bioterrorism Introduction
12.5.4 Acambis Revenue in Bioterrorism Business (2013-2018)
12.5.5 Acambis Recent Development
Browse Complete Report | http://www.reportsweb.com/global-bioterrorism-market-size-status-and-forecast-2018-2025
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
